Is There a Role for Direct Oral Anticoagulants in the Primary and Secondary Prevention of Myeloproliferative Neoplasm Associated Thrombosis?
Philadelphia chromosome negative myeloproliferative neoplasms (MPN) are clonal haematopoietic stem cell disorders. Of the MPNs, polycythaemia vera (PV) and essential thrombocythaemia (ET) confer a high thrombotic risk which may be the presenting feature of the disease. Thrombotic complications consi...
Main Authors: | Uzma Faruqi, Karen A. Breen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Hemato |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-6357/2/4/53 |
Similar Items
-
Clinical characteristics and symptom burden of Thai myeloproliferative neoplasm patients
by: Naritsara Cherdchoo, et al.
Published: (2023-12-01) -
Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives
by: Julian Baumeister, et al.
Published: (2021-12-01) -
Impact of mutations on pregnancy outcome in patients with myeloproliferative neoplasms
by: Dawn Maze, et al.
Published: (2023-02-01) -
Definitions, Biology, and Current Therapeutic Landscape of Myelodysplastic/Myeloproliferative Neoplasms
by: Margo B. Gerke, et al.
Published: (2023-07-01) -
The Approach to Thrombosis Prevention across the Spectrum of Philadelphia-Negative Classic Myeloproliferative Neoplasms
by: Steffen Koschmieder
Published: (2021-06-01)